Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use

Vaccine

Volumn 23, Issue 38, 2005, Pages 4647-4657

  Thomson, Scott A ^a   Jaramillo, Angel B ^b   Shoobridge, Maryanne ^a   Dunstan, Kerrie J ^b,c   Everett, Beth ^b   Ranasinghe, Charani ^a   Kent, Stephen J ^d   Gao, Ke ^a   Medveckzy, Jill ^a   Ffrench, Rosemary A ^b,e   Ramshaw, Ian A ^a  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e BURNET INSTITUTE   (Australia)

Author keywords

Synthetic HIV vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AIDS VACCINES; AMINO ACID MOTIFS; ANIMALS; CONSENSUS SEQUENCE; EPITOPES; HIV ANTIGENS; HIV INFECTIONS; HUMANS; IMMUNIZATION; MICE; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 23644454804     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.04.045     Document Type: Article

References (29)

1. M.P. Girard, T.D. Mastro, and W. Koff Human immunodeficiency virus. Ch. 44 S.A. Plotkin W.A. Orenstein Vaccine 4th ed. 2003 Elsevier Publications 1219-58
2. A. McMichael, and T. Hanke The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible? Nat Rev Immunol 2 2002 283 291
3. B. Gaschen, J. Taylor, K. Yusim, B. Foley, D. Lang, and V. Novitsky Diversity considerations in HIV-1 vaccine selection Science 296 2002 2354 2360
4. G. Nabel, W. Makgoba, and J. Esparza HIV-1 diversity and vaccine development Science 296 2002 2335
5. K. Yusim, C. Kesmir, B. Gaschen, M.M. Addo, M. Altfeld, and S. Brunak Clustering patterns of cytotoxic T-lyphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation J Virol 76 2002 8757 8768
6. G. Ferrari, W. Neal, A. Jones, N. Olender, J. Ottinger, and R. Ha CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition Immunol Lett 79 2001 37 47
7. B. Korber, B. Hahn, B. Foley, J.W. Mellors, T. Leitner, and G. Myers Human retroviruses and AIDS A compilation and analysis of nucleic acid and amino acid sequences. Theoretical biology and biophysics group Los Alamos 1997
8. F. Gao, D.L. Robertson, S.G. Morrison, H. Hui, S. Craig, and P.N. Fultz The heterosexual HIV-1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin J Virol 70 1996 7013 7029
9. M.O. Salminen, B. Johansson, A. Sonnerborg, S. Ayehunie, D. Gotte, and P. Leinikki Full length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C AIDS Res Hum Retro 12 1996 1329 1339
10. M. Del Val, H. Schlicht, T. Ruppert, M.J. Reddehase, and U.H. Koszinowski Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein Cell 66 1991 1145 1153
11. G.S. Sandhu, R.A. Aleff, and B.C. Kline Dual asymmetric PCR: one-step construction of synthetic genes Biotechniques 12 1992 14 16
12. S.A. Thomson, M. Sherritt, J. Medveczky, S. Elliott, D.J. Moss, and Fernando GJP Delivery of multiple CD8+ cytotoxic T cell epitopes by DNA vaccination J Immunol 160 1998 1717 1723
13. Coupar BEH, M.E. Andrew, and D.B. Boyle A general method for construction of recombinant vaccinia viruses expressing multiple foreign genes Gene 68 1988 1 10
14. H.G. Heine, and D.B. Boyle Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens Arch Virol 131 1993 277 292
15. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J Virol 72 1998 10180 10188
16. M.J. Estecourt, A.J. Ramsay, A. Brooks, S.A. Thomson, C.J. Medveckzy, and I.A. Ramshaw Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population Int Immunol 14 2002 31 37
17. S. Oehen, and K. Brduscha-Riem Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division J Immunol 161 1998 5338 5342
18. F. Gao, Y. Li, J.M. Decker, F.W. Peyerl, F. Bibollet-Ruche, and C.M. Rodenburg Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice AIDS Res Hum Retroviruses 19 9 2003 817 823
19. J. Cohen Vaccines: monkey puzzles Science 296 2002 2325 2328
20. AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH.
21. The Australian Thai HIV Vaccine Consortium. Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding 5 shared HIV-1 genes: safety and T cell immunogenicity in macaques. Vaccine 2005;23:1949-56.
22. S.A. Thomson, S.L. Elliott, M.A. Sherritt, K.W. Sproat, Coupar BEH, and A.A. Scalzo Recombinant polyepitope vaccines for the delivery of multiple CD8+ cytotoxic T cell epitopes J Immunol 157 1996 822 826
23. T. Hanke, A.J. McMichael, M. Mwau, E.G. Wee, I. Ceberej, and S. Patel Development of a DNA-MVA/HIVA vaccine for Kenya Vaccine 20 2002 1995 1998
24. M.J. Selby, B. Doe, and C.M. Walker Virus-specific cytotoxic T-lymphocyte activity elicited by co-immunisation with human immunodeficiency virus type 1 genes regulated by the bacteriophage T7 promoter and T7 RNA polymerase protein J Virol 71 1997 7827 7831
25. D.R. Casimiro, A. Tang, H.C. Perry, R.S. Long, M. Chen, and G.J. Heidecker Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene J Virol 76 1 2002 185 194
26. K.R. Young, J.M. Smith, and T.M. Ross Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle Virology 327 2 2004 262 272
27. J. Engelmayer, M. Larsson, M. Subklewe, A. Chahroudi, W.I. Cox, and R.M. Steinman Vaccinia virus inhibits the maturation of human dendritic cells: a noval mechanism of immune evasion J Immunol 163 12 1999 6762 6768
28. W. Akahata, Z.Y. Yang, and G.J. Nabel Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine J Virol 79 1 2005 626 631
29. J.F. Fonteneau, D.G. Kavanagh, M. Lirvall, C. Sanders, T.L. Cover, and N. Bhardwaj Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells Blood 102 13 2003 4448 4455